On the other hand, anti-VEGF therapy can also decrease Treg, either by inhibiting accumulation of myeloid-derived suppressor cell (MDSC) and immature dendric cell (DC) in the tumor microenvironment or directly through VEGF pathway inhibition on Treg [31–33]. The gene discussed is VEGFA; the disease is neoplasm.